HER2-Mediated Internalization of Cytotoxic Agents in
Journal
Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
24
02
2020
revised:
09
03
2020
accepted:
10
03
2020
pubmed:
28
3
2020
medline:
16
11
2021
entrez:
28
3
2020
Statut:
ppublish
Résumé
Amplification of and oncogenic mutations in
Identifiants
pubmed: 32213539
pii: 2159-8290.CD-20-0215
doi: 10.1158/2159-8290.CD-20-0215
pmc: PMC7196485
mid: NIHMS1577191
doi:
Substances chimiques
ERBB2 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
674-687Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA234361
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA190642
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA129243
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA217169
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA160001
Pays : United States
Organisme : NIH HHS
ID : U54 OD020355
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
©2020 American Association for Cancer Research.
Références
N Engl J Med. 2020 Feb 13;382(7):610-621
pubmed: 31825192
Oncogene. 2009 Feb 12;28(6):803-14
pubmed: 19060928
J Clin Oncol. 2019 Oct 10;37(29):2601-2609
pubmed: 31442103
J Thorac Oncol. 2019 Jun;14(6):1086-1094
pubmed: 30825613
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Clin Cancer Res. 2016 Oct 15;22(20):5097-5108
pubmed: 27026201
Cancer Cell. 2019 Oct 14;36(4):444-457.e7
pubmed: 31588020
Ann Oncol. 2004 Jan;15(1):19-27
pubmed: 14679114
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
J Biol Chem. 1996 Sep 13;271(37):22796-801
pubmed: 8798456
Ann Oncol. 2019 Mar 1;30(3):447-455
pubmed: 30596880
Eur J Cancer. 2019 Mar;109:28-35
pubmed: 30685684
Cancer Lett. 2016 Nov 28;382(2):176-185
pubmed: 27597738
N Engl J Med. 2020 Feb 13;382(7):597-609
pubmed: 31825569
Lancet Oncol. 2019 Jun;20(6):827-836
pubmed: 31047804
J Thorac Oncol. 2014 Dec;9(12):1750-62
pubmed: 25247338
Nucleic Acids Res. 2016 Sep 19;44(16):e131
pubmed: 27270079
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1542-1545
pubmed: 26898815
Cell. 2020 Mar 5;180(5):895-914.e27
pubmed: 32142680
Lancet Oncol. 2016 Mar;17(3):367-377
pubmed: 26874901
Mol Cancer Ther. 2004 Dec;3(12):1605-13
pubmed: 15634654
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12847-52
pubmed: 12239347
Clin Cancer Res. 2019 Dec 15;25(24):7381-7387
pubmed: 31548342
Lancet Oncol. 2019 Aug;20(8):1124-1135
pubmed: 31257177
Nat Rev Cancer. 2010 Mar;10(3):194-204
pubmed: 20147901
Clin Cancer Res. 2019 Jan 1;25(1):64-72
pubmed: 30206164
Cancer Cell. 2014 Mar 17;25(3):282-303
pubmed: 24651011
Clin Cancer Res. 2007 Oct 15;13(20):6175-81
pubmed: 17947484
Ann Oncol. 2015 Jul;26(7):1421-7
pubmed: 25899785
EMBO J. 2002 May 15;21(10):2407-17
pubmed: 12006493
Cancer. 2019 Dec 15;125(24):4380-4387
pubmed: 31469421
Cancer Discov. 2017 Jun;7(6):596-609
pubmed: 28336552
J Thorac Oncol. 2018 Dec;13(12):1897-1905
pubmed: 30096481
Pharmacol Ther. 2019 Jul;199:188-196
pubmed: 30951733
Sci Signal. 2018 Oct 09;11(551):
pubmed: 30301790
Crit Rev Oncol Hematol. 2020 Apr;148:102906
pubmed: 32109716
N Engl J Med. 2019 Feb 14;380(7):617-628
pubmed: 30516102
J Pathol. 2014 Jan;232(2):219-29
pubmed: 24105684
J Clin Oncol. 2018 Aug 20;36(24):2532-2537
pubmed: 29989854
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Clin Cancer Res. 2019 Sep 15;25(18):5441-5448
pubmed: 30979742
J Thorac Oncol. 2018 Feb;13(2):273-279
pubmed: 29313813
Lancet Oncol. 2019 Jun;20(6):816-826
pubmed: 31047803